158 related articles for article (PubMed ID: 37835000)
1. Current Approach in the Management of Secondary Immunodeficiency in Patients with Hematological Malignancies: Spanish Expert Consensus Recommendations.
Boqué C; Sánchez-Ramón S; Córdoba R; Moreno C; Cabezudo E
J Clin Med; 2023 Oct; 12(19):. PubMed ID: 37835000
[TBL] [Abstract][Full Text] [Related]
2. Current clinical practice and challenges in the management of secondary immunodeficiency in hematological malignancies.
Na IK; Buckland M; Agostini C; Edgar JDM; Friman V; Michallet M; Sánchez-Ramón S; Scheibenbogen C; Quinti I
Eur J Haematol; 2019 Jun; 102(6):447-456. PubMed ID: 30801785
[TBL] [Abstract][Full Text] [Related]
3. Management of humoral secondary immunodeficiency in hematological malignancies and following hematopoietic stem cell transplantation: Regional perspectives.
Ar MC; El Fakih R; Gabbassova S; Alhuraiji A; Nasr F; Alsaeed A; Sayinalp N; Marashi M
Leuk Res; 2023 Oct; 133():107365. PubMed ID: 37643508
[TBL] [Abstract][Full Text] [Related]
4. Post-marketing observational study on 5% intravenous immunoglobulin therapy in patients with secondary immunodeficiency and recurrent serious bacterial infections.
Günther G; Dreger B
Microbiol Immunol; 2013 Jul; 57(7):527-35. PubMed ID: 23607863
[TBL] [Abstract][Full Text] [Related]
5. Agents contributing to secondary immunodeficiency development in patients with multiple myeloma, chronic lymphocytic leukemia and non-Hodgkin lymphoma: A systematic literature review.
Jolles S; Giralt S; Kerre T; Lazarus HM; Mustafa SS; Ria R; Vinh DC
Front Oncol; 2023; 13():1098326. PubMed ID: 36824125
[TBL] [Abstract][Full Text] [Related]
6. A clinician survey for management of the secondary immunodeficiency caused by hematological malignancies in China.
Ye C; Liu J; Song X; Zheng S; Liu J
Medicine (Baltimore); 2021 Jan; 100(3):e23935. PubMed ID: 33545966
[TBL] [Abstract][Full Text] [Related]
7. A French observational study describing the use of human polyvalent immunoglobulins in hematological malignancy-associated secondary immunodeficiency.
Benbrahim O; Viallard JF; Choquet S; Royer B; Bauduer F; Decaux O; Crave JC; Fardini Y; Clerson P; Lévy V
Eur J Haematol; 2018 Jul; 101(1):48-56. PubMed ID: 29644723
[TBL] [Abstract][Full Text] [Related]
8. Burden of Infection in Patients With and Without Secondary Immunodeficiency Disease Following Diagnosis of a Mature B Cell Malignancy.
Richter J; Davids MS; Anderson-Smits C; Kamieniak M; Ren K; Hull M; Multani JK; Shah D; Siffel C
Clin Lymphoma Myeloma Leuk; 2024 Apr; ():. PubMed ID: 38734499
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of hypogammaglobulinemia and its management with subcutaneous immunoglobulin supplementation in patients after allogeneic hematopoietic stem cell transplantation-a single-center analysis.
Karakulska-Prystupiuk E; Dwilewicz-Trojaczek J; Drozd-Sokołowska J; Kmin E; Chlebus M; Szczypińska K; Boguradzki P; Tomaszewska A; Mądry K; Biliński J; Basak GW; Jędrzejczak WW
Ann Hematol; 2021 Dec; 100(12):3007-3016. PubMed ID: 34477951
[TBL] [Abstract][Full Text] [Related]
10. Controversies about immunoglobulin replacement therapy in HSCT recipients with hypogammaglobulinemia.
Ohmoto A; Fuji S; Shultes KC; Savani BN; Einsele H
Bone Marrow Transplant; 2022 Jun; 57(6):874-880. PubMed ID: 35440805
[TBL] [Abstract][Full Text] [Related]
11. Guidelines on the use of intravenous immune globulin for hematologic conditions.
Anderson D; Ali K; Blanchette V; Brouwers M; Couban S; Radmoor P; Huebsch L; Hume H; McLeod A; Meyer R; Moltzan C; Nahirniak S; Nantel S; Pineo G; Rock G
Transfus Med Rev; 2007 Apr; 21(2 Suppl 1):S9-56. PubMed ID: 17397769
[TBL] [Abstract][Full Text] [Related]
12. Incidence of infection according to intravenous immunoglobulin use in autologous hematopoietic stem cell transplant recipients with multiple myeloma.
Park S; Jung CW; Jang JH; Kim SJ; Kim WS; Kim K
Transpl Infect Dis; 2015 Oct; 17(5):679-87. PubMed ID: 26201517
[TBL] [Abstract][Full Text] [Related]
13. Serum Free Light Chains in Common Variable Immunodeficiency Disorders: Role in Differential Diagnosis and Association With Clinical Phenotype.
Scarpa R; Pulvirenti F; Pecoraro A; Vultaggio A; Marasco C; Ria R; Altinier S; Compagno N; Firinu D; Plebani M; De Carli M; Matucci A; Vianello F; Vacca A; Spadaro G; Quinti I; Agostini C; Milito C; Cinetto F
Front Immunol; 2020; 11():319. PubMed ID: 32296413
[TBL] [Abstract][Full Text] [Related]
14. [Hypogammaglobulinemia and immunodeficiency in multiple myeloma and chronic lymphoid leukemia].
Matthes T; Jandus P
Rev Med Suisse; 2023 Apr; 19(821):668-673. PubMed ID: 37017348
[TBL] [Abstract][Full Text] [Related]
15. Subcutaneous Immunoglobulin Therapy for Hypogammaglobulinemia Secondary to Malignancy or Related Drug Therapy.
Windegger TM; Lambooy CA; Hollis L; Morwood K; Weston H; Fung YL
Transfus Med Rev; 2017 Jan; 31(1):45-50. PubMed ID: 27450021
[TBL] [Abstract][Full Text] [Related]
16. An Immune Recovery-Based Revaccination Protocol for Pediatric Hematopoietic Stem Cell Transplant Recipients: Revaccination Outcomes Following Pediatric HSCT.
Haynes AS; Curtis DJ; Campbell K; Giller RH; Quinones RR; Verneris MR; Abzug MJ
Transplant Cell Ther; 2021 Apr; 27(4):317-326. PubMed ID: 33836875
[TBL] [Abstract][Full Text] [Related]
17. Immunoglobulin prophylaxis in pediatric hematopoietic stem cell transplant.
Foster JH; Cheng WS; Nguyen NY; Krance R; Martinez C
Pediatr Blood Cancer; 2018 Dec; 65(12):e27348. PubMed ID: 30207052
[TBL] [Abstract][Full Text] [Related]
18. Immunoglobulin substitution in patients with secondary antibody deficiency in chronic lymphocytic leukemia and multiple myeloma: a representative analysis of guideline adherence and infections.
Link H; Kerkmann M; Holtmann L; ;
Support Care Cancer; 2022 Jun; 30(6):5187-5200. PubMed ID: 35257229
[TBL] [Abstract][Full Text] [Related]
19. Prophylaxis against infections with low-dose intravenous immunoglobulins (IVIG) in chronic lymphocytic leukemia. Results of a crossover study.
Molica S; Musto P; Chiurazzi F; Specchia G; Brugiatelli M; Cicoira L; Levato D; Nobile F; Carotenuto M; Liso V; Rotoli B
Haematologica; 1996; 81(2):121-6. PubMed ID: 8641639
[TBL] [Abstract][Full Text] [Related]
20. Treating secondary antibody deficiency in patients with haematological malignancy: European expert consensus.
Jolles S; Michallet M; Agostini C; Albert MH; Edgar D; Ria R; Trentin L; Lévy V
Eur J Haematol; 2021 Apr; 106(4):439-449. PubMed ID: 33453130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]